Skip to content

Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

Glycatetd Hemoglobin Index and Red Cell Distribution Width as Prognstic Indicator in Critical Ill Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07057154
Enrollment
97
Registered
2025-07-09
Start date
2025-07-05
Completion date
2026-12-02
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Ill Patients

Brief summary

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Detailed description

Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units. b. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.

Interventions

DEVICEHbg and RDW

Hbg and RDW as prognstic indicator in critical ill patients

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

1. patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis 2. diabtic Patients 3-animic Patients

Exclusion criteria

* Patients under 18 years of age * ICU stay \< 24 h * patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .

Design outcomes

Primary

MeasureTime frameDescription
Glycated Hemoglobin levelBaselineMeasurement of Hb level in all patients upon ICU admission.
Red Cell Distribution Width (RDW)baselineMeasurement of RDW in all patients upon ICU admission.
Hemoglobin (Hb) LevelbaselineMeasurement of Hb level in all patients upon ICU admission.

Contacts

Primary ContactRania Moukhter Aziz eldeam
Moukhterrania@gmail.com+201022004702
Backup ContactAlaa ELdean Abd Elmoniem, Prof
alaaelmoniem@aun.edu.eg+201112732730

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026